Additionally, several months of therapy restores the balance of cytokines by reducing the level of TNF-α [8, 9] and increasing the level of IL-2 and IL-10 [4, 8, 9] in whole blood cell cultures of HD patients during treatment. The gene discussed is IL2; the disease is Huntington disease.